Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type ( Voriconazole, Liposomal, Amphotericin B, Systemic Oral Azoles, Topical, Antifungal Agents, Others ); Application ( Chronic, Pulmonary Aspergillosis (CPA), Allergic, Bronchopulmonary Aspergillosis (ABPA), Gastrointestinal Candidasis, Genitourinary Tract Candidasis, Others ), and Geography

Market Introduction

Fungal systemic infections are common in patients with weakened immune system, including immunosuppression and acquired immunodeficiency syndrome (AIDS) patients. Systemic signs consolidate apnea, guaiac-positive stools, abdominal distension, hyperglycemia, leukemoid reaction, hypotension, and others. The treatment of systemic candidiasis and aspergillos need parenteral antifungal therapy and this condition is associated with high mortality rate. Furthermore, this infection may result in permanent neurodevelopmental deficits in long-term survivors.

Get more information on this report :

Market Overview and Dynamics

The Middle East and Africa systemic aspergillosis and systemic candidasis market is projected to reach US$ 2,237.55 million by 2027 from US$ 184.03 million in 2019; it is estimated to grow with a CAGR of 3.0% from 2020 to 2027. The growth of the Middle East and Africa systemic aspergillosis and systemic candidasis market is attributed to the rise in prevalence of fungal diseases, rising hospital acquired fungal infection. However, increasing resistance to antifungal drugs, side effects of antifungal drugs limits the growth of market in this region. Countries in Middle East and Africa are expecting to witness huge challenge due to growing COVID-19. Due to outbreak of disease, healthcare industries has been affected badly and many business related activities such as product launches and product promotion conferences has been postponed, leading to restraining the growth of the market.

Key Market Segments

Based on type, the Middle East and Africa systemic aspergillosis and systemic candidasis market is segmented into voriconazole, liposomal, amphotericin b, systemic oral azoles, topical, antifungal agents, and others. In 2019, the systemic oral azoles segment held a larger share of the market. And is expected to grow at a faster rate during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to while preparing the Middle East and Africa systemic aspergillosis and systemic candidasis Market report are World Health Organization, Ministry of Health and Prevention, and Ministry of Health and Family Welfare.

Novartis AG, Sanofi, Pfizer Inc., Merck & Co., Inc., Bayer AG, Astellas Pharma Inc., GlaxoSmithKline plc., Abbott, Cipla Inc.

Reasons to buy the report

To understand the Middle East and Africa systemic aspergillosis and systemic candidasis market landscape and identify market segments that are most likely to guarantee a strong return
To stay ahead in comprehending the ever-changing competitive landscape of the Middle East and Africa systemic aspergillosis and systemic candidasis market
To efficiently plan M&A and partnership deals in the Middle East and Africa systemic aspergillosis and systemic candidasis market by identifying market segments with the most promising probable sales
To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Middle East and Africa systemic aspergillosis and systemic candidasis market
To obtain market revenue forecast from 2019 to 2027 in various segments of the Middle East and Africa systemic aspergillosis and systemic candidasis market

MIDDLE EAST AND AFRICA SYSTEMIC ASPERGILLOSIS AND SYSTEMIC CANDIDASIS MARKET SEGMENTATION

By Type

Systemic Oral Azoles
Voriconazole
Liposomal Amphotericin B
Topical Antifungal Agents
Others

By Application

Allergic Bronchopulmonary Aspergillosis (ABPA)
Chronic Pulmonary Aspergillosis (CPA)
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Others

By Country

South Africa
Saudi Arabia
UAE
Rest of Middle East and Africa

Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market – By Type

1.3.2 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market – By Application

1.3.3 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market – By Country

2. Systemic Aspergillosis And Systemic Candidasis Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinions

4.4 Clinical Trials Phases of Products Offered by Companies

4.5 Candida Specific Marketed Products

5. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rise in Prevalence of Fungal Diseases

5.1.2 Rising Hospital Acquired Fungal Infection

5.2 Market Restraints

5.2.1 Increasing Resistance to Antifungal Drugs

5.2.2 Side Effects of Antifungal Drugs

5.3 Market Opportunities

5.3.1 Increase in R&D Activities and Pipeline of New Drug

5.4 Future Trends

5.4.1 Consolidation of Market

5.5 Impact Analysis

6. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Type

6.1 Overview

6.2 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

6.3 Voriconazole

6.3.1 Overview

6.3.2 Middle East & Africa Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)

6.4 Liposomal Amphotericin B

6.4.1 Overview

6.4.2 Middle East & Africa Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

6.5 Systemic Oral Azoles

6.5.1 Overview

6.5.2 Middle East & Africa Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

6.6 Topical Antifungal Agents

6.6.1 Overview

6.6.2 Middle East & Africa Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

6.7 Others

6.7.1 Overview

6.7.2 Middle East & Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

7. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Application

7.1 Overview

7.2 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

7.3 Chronic Pulmonary Aspergillosis (CPA)

7.3.1 Overview

7.3.2 Middle East & Africa Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.4 Allergic Bronchopulmonary Aspergillosis (ABPA)

7.4.1 Overview

7.4.2 Middle East & Africa Allergic bronchopulmonary aspergillosis (ABPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 Gastrointestinal Candidasis

7.5.1 Overview

7.5.2 Middle East & Africa Gastrointestinal Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.6 Genitourinary Tract Candidasis

7.6.1 Overview

7.6.2 Middle East & Africa Genitourinary Tract Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.7 Others

7.7.1 Overview

7.7.2 Middle East & Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market – Regional Analysis

8.1 Overview

8.1.1 Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.2 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.3 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.4 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Country, 2019 & 2027 (%)

8.1.5 South Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.1 South Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.2 South Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.5.3 South Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.6 Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.1 Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.2 Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.6.3 Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.7 UAE: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.1 UAE: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.2 UAE: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.7.3 UAE: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.8 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.1 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.2 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.8.3 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

9. Impact of COVID-19 Pandemic on Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market

9.1 Middle East and Africa Impact Assessment of COVID-19 Pandemic

10. COMPANY PROFILES

10.1 Novartis AG

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Products and Services

10.1.4 Financial Overview

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Sanofi

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Products and Services

10.2.4 Financial Overview

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 Pfizer Inc.

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Products and Services

10.3.4 Financial Overview

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Merck & Co., Inc.

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Products and Services

10.4.4 Financial Overview

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Bayer AG

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Products and Services

10.5.4 Financial Overview

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 GlaxoSmithKline plc.

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Products and Services

10.6.4 Financial Overview

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Abbott

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Products and Services

10.7.4 Financial Overview

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 Cipla Inc.

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Products and Services

10.8.4 Financial Overview

10.8.5 SWOT Analysis

10.8.6 Key Developments

11. Appendix

11.1 About the Insight Partners

11.2 Glossary of Terms

LIST OF TABLES

Table 1. Clinical Trials Phases of Products Offered by Companies

Table 2. Candida Specific Marketed Products

Table 3. Clinical cases of Candida auris reported by U.S. states, as of November 30, 2020

Table 4. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6. US: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 7. South Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027

Table 8. Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9. Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10. UAE: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11. UAE: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12. Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 13. Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 14. Glossary of Terms, Systemic Aspergillosis And Systemic Candidasis Market

LIST OF FIGURES

Figure 1. Systemic Aspergillosis And Systemic Candidasis Market Segmentation

Figure 2. Systemic Aspergillosis And Systemic Candidasis Market, By Country

Figure 3. Middle East & Africa Systemic Aspergillosis And Systemic Candidasis Market Overview

Figure 4. Systemic Oral Azoles Segment Held Largest Share of Type Segment In Systemic Aspergillosis And Systemic Candidasis Market

Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. PEST Analysis

Figure 7. Systemic Aspergillosis and Systemic Candidasis Market Impact Analysis of Drivers and Restraint

Figure 8. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 9. Middle East & Africa Voriconazole Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 10. Middle East & Africa Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11. Middle East & Africa Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12. Middle East & Africa Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13. Middle East & Africa others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 15. Middle East & Africa Chronic pulmonary aspergillosis (CPA) Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 16. Middle East & Africa Allergic bronchopulmonary aspergillosis (ABPA)Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17. Middle East & Africa Gastrointestinal Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18. Middle East & Africa Genitourinary Tract Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19. Middle East & Africa others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Key Country – Revenue (2019) (USD Million)

Figure 21. Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market Revenue and Forecast to 2027 (USD Million)

Figure 22. Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Country, 2019 & 2027 (%)

Figure 23. South Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 24. Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 25. UAE: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 26. Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 27. Impact Of COVID-19 Pandemic in Middle East and Africa Market

To understand the Middle East and Africa systemic aspergillosis and systemic candidasis market landscape and identify market segments that are most likely to guarantee a strong return
To stay ahead in comprehending the ever-changing competitive landscape of the Middle East and Africa systemic aspergillosis and systemic candidasis market
To efficiently plan M&A and partnership deals in the Middle East and Africa systemic aspergillosis and systemic candidasis market by identifying market segments with the most promising probable sales
To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Middle East and Africa systemic aspergillosis and systemic candidasis market
To obtain market revenue forecast from 2019 to 2027 in various segments of the Middle East and Africa systemic aspergillosis and systemic candidasis market

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample